Target intelligence / Profile preview

BIRC6 antisense RNA 1 (BIRC6-AS1)

Target: BIRC6-AS1
Molecular classification: Long non-coding RNA (lncRNA), Other

Overview

BIRC6 antisense RNA 1 (BIRC6-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand at the BIRC6 locus. Little to no direct functional characterization exists for BIRC6-AS1 in the peer-reviewed literature. Its name and locus suggest a potential function in regulating the expression of BIRC6, a gene with substantial roles in cell survival and apoptosis, but BIRC6-AS1 itself is not a canonical protein, enzyme, receptor, or validated therapeutic target. Most knowledge, biological rationale, and disease association in this genomic region pertain to the coding gene BIRC6 (BRUCE/Apollon), not to BIRC6-AS1. Note: If the intent was to refer to BIRC6 (BRUCE/Apollon)—a ubiquitin-conjugating inhibitor of apoptosis protein highly relevant to cancer biology and targeted by antisense oligonucleotides—please clarify. All major research, drug development, and mechanistic literature concern BIRC6 and not the antisense RNA BIRC6-AS1.

Other names: BIRC6-AS1lncRNA BIRC6-AS1

Biological functions

Unknown; potentially regulatory (lncRNAs often regulate gene expression epigenetically or post-transcriptionally), but no well-documented, specific roles for BIRC6-AS1 in the literature

Disease associations

Other (potential, not established); lncRNAs as a class are implicated in cancer and other diseases, but there is no established role for BIRC6-AS1 itself

Beyond the preview

Go deeper on BIRC6 antisense RNA 1 (BIRC6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIRC6 antisense RNA 1 (BIRC6-AS1).

Explore the full profile